Form D · Other Health Care
Javelin Oncology, Inc.
Lebanon, NH · CIK 0001796219
Offering snapshot reported Dec 10, 2019 · SEC filing
- Reported sold
- $1.5M Offering amount: $3M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 5, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2019 | Initial | $1,500,000 | No comparison | 10 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-355190
Source: Form D, filed Dec 10, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eric Achtman | Director |
| Anthony Cooper | Executive |
| Matthew Martin | Executive |
| Jake Reder | Director |
| Daniel Rhodes | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
16 Cavendish Ct. Suite 241
Lebanon, NH, 03766
Lebanon, NH, 03766